Back to top

Morgan Stanley Reaffirms Their Buy Rating on Biogen (BIIB)

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of $2...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Biogen Inc. (BIIB)